We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: The integrated polygenic risk score combines information from multiple genetic variants into a single test that provides a result for each of eight cardiovascular conditions (photo credit: Adobe Stock)

Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions

A validated polygenic risk score flags high inherited risk across eight cardiovascular conditions often missed by calculators. More...
30 Apr 2026
Image: Ex vivo drug screening workflow for AML patient samples. (Grassi, F., Bast, L., Singh, M. et al. Discover Oncology (2026). https://doi.org/10.1007/s12672-026-04880-x)

Routine Genetic Marker May Help Guide Targeted Therapy in Acute Leukemia

A routine mutation test flags AML patients likely to benefit from DCPS inhibitors. More...
30 Apr 2026
Image: CareDx entered an agreement to acquire Naveris for $160 million upfront, with up to $100 million in additional milestone payments.

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition

CareDx entered an agreement to acquire Naveris for $160 million upfront, with up to $100 million in additional milestone payments. More...
29 Apr 2026
Image: The blood test uses an immune-profiling method to detec germ cell tumors, the most common form of testicular cancer (photo credit: Adobe Stock)

Blood Test Detects Testicular Cancer Missed by Standard Markers

A new immune-profiling blood test detects germ cell tumors, even when standard markers are negative, improving diagnosis. More...
29 Apr 2026
Image: The indices are presented through intuitive software on the Aquila, Aquarius 3, and Abacus 5 analyzers (photo courtesy of Diatron)

Advanced CBC-Derived Indices Integrated into Hematology Platforms

Diatron, a STRATEC brand, has introduced six advanced RUO hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers More...
29 Apr 2026
Image: Thermo Fisher expects the transaction with Astorg to close in the second half of 2026

Thermo Fisher Scientific to Sell Microbiology Business to Astorg

Thermo Fisher's microbiology portfolio of AST and culture media solutions has been acquired by Astorg. More...
29 Apr 2026
Image: A nine‑protein plasma panel that estimates the likelihood of kidney disease progression in APOL1 high‑risk individuals (photo credit: Shutterstock)

Proteomic Risk Score Predicts Kidney Disease Progression in High-Risk Patients

A new plasma proteomic score predicts CKD progression in APOL1 high-risk adults, outperforming risk calculators for early care. More...
29 Apr 2026
New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
All-in-One Molecular System
AIO M160
Copyright © 2000-2026 Globetech Media. All rights reserved.